ERYTECH Strengthens Executive Leadership Team with Appointments of Chief Scientific Officer and Chief Business Officer

admERY
October 27, 2016
Newsroom

ERYTECH today announced the appointments of Dr. Alexander Scheer, Ph.D. as the company’s Chief Scientific Officer and Jean-Sébastien Cleiftie, as Chief Business Officer.

You Might Also Like

ERYTECH Provides Update on the TRYbeCA-1 Phase 3 Clinical Trial of Eryaspase in Second Line Pancreatic Cancer

ERYTECH Granted U.S. FDA Fast Track Designation for Eryaspase in Hypersensitive ALL

ERYTECH to Host Third Quarter 2019 Conference Call and Business Update on November 8, 2019